Paper34215620
Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations.
Cheruiyot A and 18 others. Cancer Res, 2021. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring SF3B1 or U2AF1 Mutations. Papers, record 34215620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34215620
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mutation | Major topic |
| Myelodysplastic Syndromes | Major topic |
| Nonsense Mediated mRNA Decay | Major topic |
| Phosphoproteins | Major topic |
| RNA Splicing Factors | Major topic |
| Splicing Factor U2AF | Major topic |
| Cell Cycle | |
| Cell Line, Tumor | |
| Chromosomal Instability | |
| Fluorescent Dyes | |
| Gene Expression Regulation | |
| Genes, Reporter | |
| Genome-Wide Association Study | |
| Humans | |
| K562 Cells | |
| RNA-Binding Proteins | |
| RNA-Seq | |
| Ribonuclease H | |
| Spliceosomes |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA101937 | NCI NIH HHS | United States | P01CA101937 | PubMed and NIH | NIH RePORTER |
| P50 CA171963 | NCI NIH HHS | United States | P50CA171963 | PubMed and NIH | NIH RePORTER |
| R01 GM098535 | NIGMS NIH HHS | United States | R01GM098535 | PubMed and NIH | NIH RePORTER |
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29236262 | Studying Nonsense-Mediated mRNA Decay in Mammalian Cells Using a Multicolored Bioluminescence-Based Reporter System. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29236262 | PubMed |
| 2 | 30506991 | Human RNF113A participates of pre-mRNA splicing in vitro. | J Cell Biochem | 2019 | https://conductscience.org/library/papers/30506991 | PubMed |
| 3 | 21596314 | Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. | Mol Cell | 2011 | https://conductscience.org/library/papers/21596314 | PubMed |
| 4 | 12718880 | Y14 and hUpf3b form an NMD-activating complex. | Mol Cell | 2003 | https://conductscience.org/library/papers/12718880 | PubMed |
| 5 | 32001512 | Recurrent SRSF2 mutations in MDS affect both splicing and NMD. | Genes Dev | 2020 | https://conductscience.org/library/papers/32001512 | PubMed |
| 6 | 27068814 | Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells. | Nat Commun | 2016 | https://conductscience.org/library/papers/27068814 | PubMed |
| 7 | 31107948 | A null allele of Dnaaf2 displays embryonic lethality and mimics human ciliary dyskinesia. | Hum Mol Genet | 2019 | https://conductscience.org/library/papers/31107948 | PubMed |
| 8 | 27622333 | Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27622333 | PubMed |
| 9 | 29395063 | The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations. | Mol Cell | 2018 | https://conductscience.org/library/papers/29395063 | PubMed |
| 10 | 28645379 | DNA Fiber Analysis: Mind the Gap! | Methods Enzymol | 2017 | https://conductscience.org/library/papers/28645379 | PubMed |
| 11 | 28765281 | p38 MAPK inhibits nonsense-mediated RNA decay in response to persistent DNA damage in noncycling cells. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28765281 | PubMed |
| 12 | 20463739 | Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay. | Nature | 2010 | https://conductscience.org/library/papers/20463739 | PubMed |
| 13 | 28024152 | Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia. | Nat Immunol | 2017 | https://conductscience.org/library/papers/28024152 | PubMed |
| 14 | 31659324 | The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. | Nat Genet | 2019 | https://conductscience.org/library/papers/31659324 | PubMed |
| 15 | 23435113 | Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23435113 | PubMed |
| 16 | 18362164 | Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response. | Mol Cell Biol | 2008 | https://conductscience.org/library/papers/18362164 | PubMed |
| 17 | 30194306 | Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. | Nat Commun | 2018 | https://conductscience.org/library/papers/30194306 | PubMed |
| 18 | 18322460 | Isolation of an active step I spliceosome and composition of its RNP core. | Nature | 2008 | https://conductscience.org/library/papers/18322460 | PubMed |
| 19 | 24459210 | Normal and aberrant splicing of LMNA. | J Med Genet | 2014 | https://conductscience.org/library/papers/24459210 | PubMed |
| 20 | 23236153 | Human spliceosomal protein CWC22 plays a role in coupling splicing to exon junction complex deposition and nonsense-mediated decay. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/23236153 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42819770 | mRNA processing in cancer immunotherapy: emerging targets, resistance mechanisms, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42819770 | PubMed |
| 42625101 | RNA splicing in health and disease. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42625101 | PubMed |
| 42600567 | The SF3b complex in cancer: structural basis, molecular mechanisms, and therapeutic opportunities. | Blood Adv | 2026 | https://conductscience.org/library/papers/42600567 | PubMed |
| 42499671 | Global Changes in Unproductive Splicing and NMD Efficiency in Tumors. | Acta Naturae | 2026 | https://conductscience.org/library/papers/42499671 | PubMed |
| 42260649 | Nonsense-mediated mRNA decay: friend or foe in cancer biology? | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42260649 | PubMed |
| 41956098 | Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome. | Immunity | 2026 | https://conductscience.org/library/papers/41956098 | PubMed |
| 41954618 | Nonsense-Mediated RNA Decay Is a Targetable Vulnerability in Splicing Factor Mutant Myeloid Neoplasms by Enhancing R-Loop Accumulation and DNA Damage. | Cancer Res | 2026 | https://conductscience.org/library/papers/41954618 | PubMed |
| 41623476 | Pharmacological perturbation of splicing elicits SMG1 reduction: Implications for cancer therapy. | iScience | 2026 | https://conductscience.org/library/papers/41623476 | PubMed |
| 41580475 | Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41580475 | PubMed |
| 41055979 | Distinct and convergent effects of SF3B1 mutations in human breast cancer. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/41055979 | PubMed |
| 41023738 | Variable efficiency of nonsense-mediated mRNA decay across human tissues, tumors and individuals. | Genome Biol | 2025 | https://conductscience.org/library/papers/41023738 | PubMed |
| 40856040 | Direct and indirect effects of spliceosome disruption compromise gene regulation by nonsense-mediated mRNA decay. | RNA Biol | 2025 | https://conductscience.org/library/papers/40856040 | PubMed |
| 39960487 | Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape. | Elife | 2025 | https://conductscience.org/library/papers/39960487 | PubMed |
| 39384951 | Steering research on mRNA splicing in cancer towards clinical translation. | Nat Rev Cancer | 2024 | https://conductscience.org/library/papers/39384951 | PubMed |
| 39146933 | Molecular impact of mutations in RNA splicing factors in cancer. | Mol Cell | 2024 | https://conductscience.org/library/papers/39146933 | PubMed |
| 39105183 | Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis. | JHEP Rep | 2024 | https://conductscience.org/library/papers/39105183 | PubMed |
| 38995840 | RBM7 deficiency promotes breast cancer metastasis by coordinating MFGE8 splicing switch and NF-kB pathway. | Elife | 2024 | https://conductscience.org/library/papers/38995840 | PubMed |
| 38816425 | TCAF1 promotes TRPV2-mediated Ca2+ release in response to cytosolic DNA to protect stressed replication forks. | Nat Commun | 2024 | https://conductscience.org/library/papers/38816425 | PubMed |
| 38589367 | Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation. | Nat Commun | 2024 | https://conductscience.org/library/papers/38589367 | PubMed |
| 38421617 | Formation of Different Polyploids Through Disrupting Meiotic Crossover Frequencies Based on cntd1 Knockout in Zebrafish. | Mol Biol Evol | 2024 | https://conductscience.org/library/papers/38421617 | PubMed |
Genes48
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34215620
GET https://conductscience.org/api/papers/v1/34215620/references?page=2